Related Experiment Video
Updated: Jul 3, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Influenza guideline for South Africa--update 2008
This guideline updates influenza management for South Africa, recommending specific 2008 vaccines and reserving neuraminidase inhibitors for high-risk patients. It also includes new data on treatment and pediatric influenza.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The South African Thoracic Society (SATS) previously published an influenza management guideline in 1999.
- Influenza viruses, particularly Type A, pose significant clinical and epidemiological challenges due to antigenic variation in their surface proteins (HA and NA).
- Antigenic drift in the haemagglutinin (HA) protein allows influenza viruses to evade host immune responses, necessitating regular vaccine updates.
Purpose of the Study:
- To revise the 1999 Guideline for Influenza Management in Adults.
- To incorporate the specific viral strains for the 2008 influenza vaccine.
- To include updated information on influenza treatment, pediatric influenza, and management strategies for HIV-infected individuals.
Main Methods:
- Review and synthesis of current data on influenza virology, vaccination, and treatment.
- Identification of recommended influenza vaccine strains for the 2008 season.
- Inclusion of specific recommendations for managing influenza in children and HIV-infected individuals.
Main Results:
- The recommended influenza vaccine formulation for 2008 includes A/Solomon Islands/3/2006 (H1N1), A/Brisbane/10/2007 (H3N2), and B/Florida/4/2006 or B/Brisbane/3/2007.
- Influenza vaccination is recommended for high-risk individuals, including those with chronic medical conditions and immunosuppressed individuals (e.g., HIV-infected persons).
- Neuraminidase (NA) inhibitors are recommended as an adjunct for influenza prevention and treatment but should be reserved for high-risk or severely ill patients due to resistance concerns. Amantadine and rimantadine are not recommended for influenza A treatment or prophylaxis.
Conclusions:
- The revised guideline provides updated recommendations for influenza prevention and management in South Africa for 2008.
- Vaccination remains the primary strategy for influenza prevention, particularly for high-risk populations.
- Judicious use of antiviral agents like NA inhibitors is crucial for effective influenza treatment while mitigating resistance.
More Related Videos
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Influenza
Respiratory Syncytial Virus Disease
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Inhibitors Of Virion Release
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: